CONFERENCE COVERAGE SERIES
Society for Neuroscience Annual Meeting 2005
Washington, DC, U.S.A.
12 – 16 November 2005
SfN: R-Flurbiprofen Phase 2 Trial Results
When it comes to human tests of prospective Alzheimer disease treatments, researchers have learned to be humble...
SfN: How to Dispose of Plaques? Closing Spigot Won’t Do; Enzymes Nibble
Oligomeric forms of amyloid-β (and also early pretangle forms of tau) captured much of the buzz at the 35th Annual Meeting of the Society for Neuroscience...
SfN: Return of the Other—Tau Is Back, Part 1
This year’s 35th annual meeting of the Society for Neuroscience had groups of researchers share a common sense of excitement about...
SfN: Return of the Other—Tau Is Back, Part 2
This is the second installment of a four-part news series about the role of the microtubule-associated protein tau from the 35th Annual Conference of the Society for Neuroscience...
SfN: Return of the Other—Tau Is Back, Part 3
This is the third installment of a four-part news series about the role of the microtubule-associated protein tau from the 35th Annual Conference of the Society for Neuroscience...
SfN: Return of the Other—Tau Is Back, Part 4
This is the last installment of a four-part news series about the role of the microtubule-associated protein tau from the 35th Annual Conference of the Society for Neuroscience...
SfN: Where, How Does Intraneuronal Aβ Pack Its Punch? Part 1
The story of intraneuronal Aβ has generated a steady buzz at the 35th Annual Meeting of the Society for Neuroscience...
SfN: Where, How Does Intraneuronal Aβ Pack Its Punch? Part 2
This is the second installment of a four-part news series about intraneuronal Aβ from the 35th Annual Conference of the Society for Neuroscience...
SfN: Where, How Does Intraneuronal Aβ Pack Its Punch? Part 3
This is the third installment of a four-part news series about intraneuronal Aβ from the 35th Annual Conference of the Society for Neuroscience...
SfN: Where, How Does Intraneuronal Aβ Pack Its Punch? Part 4
This is the final installment of a four-part news series about the role of intraneuronal Aβ from the 35th Annual Conference of the Society for Neuroscience...
SfN: Early Steps toward Parkinson Disease Blood Test
Biomarkers are the buzz of the field these days, and the hum was heard inside the beltway at the 35th Annual Conference of the Society for Neuroscience...
SfN: Latest Intel on LRRK2, Parkin
In the aftermath of a recent spate of gene discoveries for Parkinson disease, some of the prizes scientists were chasing...
SfN: Amyloid Oligomers—Not So Elusive, After All? Part 1
For the past decade, Alzheimer researchers have gradually built the argument that...
SfN: Amyloid Oligomers—Not So Elusive, After All? Part 2
This story continues the <a href="/news/conference-coverage/sfn-amyloid-oligomers-not-so-elusive-after-all-part-1">Introduction/Part 1</a> of our SfN conference news update on Aβ oligomers...
SfN: P25 at Synapses—A Bite Peps Up, A Binge Crashes the System
One poster that stood out at last month’s 35th Annual Conference of the Society for Neuroscience was that of...
SfN: Nature or Nurture—Epigenetics in Neuronal Responses
Take a break from Aβ and tau, and consider something completely different...
SfN: Channeling Selective Toxicity in Parkinson Disease
One of the puzzles of Parkinson pathology is why death comes to only a subpopulation of neurons in the midbrain...
SfN: EPO—Not Just for Blood Cells Anymore, but Neurons, Too
Erythropoietin (EPO), produced by the kidney in response to low serum oxygen, is a major stimulant for...